CN1668638A - 来自节杆菌的Hsp70 - Google Patents
来自节杆菌的Hsp70 Download PDFInfo
- Publication number
- CN1668638A CN1668638A CNA038170477A CN03817047A CN1668638A CN 1668638 A CN1668638 A CN 1668638A CN A038170477 A CNA038170477 A CN A038170477A CN 03817047 A CN03817047 A CN 03817047A CN 1668638 A CN1668638 A CN 1668638A
- Authority
- CN
- China
- Prior art keywords
- sequence
- hsp70
- protein
- arthrobacter
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0233—Rickettsiales, e.g. Anaplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/827—Bacterial vaccine for fish
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
Description
Claims (30)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0216414.3A GB0216414D0 (en) | 2002-07-15 | 2002-07-15 | Organic compounds |
GB0216414.3 | 2002-07-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1668638A true CN1668638A (zh) | 2005-09-14 |
CN100378124C CN100378124C (zh) | 2008-04-02 |
Family
ID=9940485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB038170477A Expired - Fee Related CN100378124C (zh) | 2002-07-15 | 2003-07-14 | 来自节杆菌的Hsp70 |
Country Status (16)
Country | Link |
---|---|
US (1) | US7674892B2 (zh) |
EP (1) | EP1523497B1 (zh) |
JP (1) | JP5362167B2 (zh) |
CN (1) | CN100378124C (zh) |
AT (1) | ATE499381T1 (zh) |
AU (1) | AU2003250943B2 (zh) |
BR (1) | BR0312700A (zh) |
CA (1) | CA2492556C (zh) |
CL (1) | CL2007002806A1 (zh) |
DE (1) | DE60336141D1 (zh) |
DK (1) | DK1523497T3 (zh) |
GB (1) | GB0216414D0 (zh) |
HK (1) | HK1075901A1 (zh) |
NO (1) | NO337573B1 (zh) |
TW (1) | TWI332989B (zh) |
WO (1) | WO2004007539A2 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103405763A (zh) * | 2013-07-15 | 2013-11-27 | 中国科学院海洋研究所 | 热休克蛋白70作为免疫佐剂的应用 |
CN106282196A (zh) * | 2016-08-20 | 2017-01-04 | 辽宁省海洋水产科学研究院 | 中华绒螯蟹hsp90基因克隆及其应用 |
CN108929880A (zh) * | 2012-03-27 | 2018-12-04 | 库瑞瓦格股份公司 | 包含5′toputr的人工核酸分子 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0303507D0 (en) | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
DE102005010288A1 (de) * | 2005-03-02 | 2006-09-07 | Riemser Arzneimittel Ag | Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung |
AU2007340158A1 (en) * | 2006-12-29 | 2008-07-10 | Revance Therapeutics, Inc. | Transport molecules using reverse sequence HIV-TAT polypeptides |
EP2318032B1 (en) * | 2008-06-26 | 2012-04-04 | Orphazyme APS | Use of hsp70 as a regulator of enzymatic activity |
US9345760B2 (en) | 2011-09-09 | 2016-05-24 | Advanced Bionutrition Corporation | IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same |
US8450107B1 (en) | 2011-11-30 | 2013-05-28 | The Broad Institute Inc. | Nucleotide-specific recognition sequences for designer TAL effectors |
CN109069496A (zh) | 2016-04-29 | 2018-12-21 | 奥菲泽米有限公司 | 用于治疗葡糖脑苷脂酶相关疾病的arimoclomol |
WO2022106614A1 (en) | 2020-11-19 | 2022-05-27 | Orphazyme A/S | Processes for preparing arimoclomol citrate and intermediates thereof |
WO2023162731A1 (ja) * | 2022-02-22 | 2023-08-31 | 株式会社ニッスイ | ワクチン接種方法及び養殖魚 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2666588B1 (fr) * | 1990-09-10 | 1994-02-11 | Pasteur Institut | Sequence nucleotidique regulatrice de l'initiation de transcription. |
GB9701897D0 (en) | 1997-01-30 | 1997-03-19 | Aqua Health Europ Ltd | Vaccine |
DK1200132T4 (da) | 1999-08-07 | 2010-04-19 | Novartis Ag | Nucleinsyre-og aminosyresekvenser af infektiøs lakseanæmivirus og deres anvendelse som vacciner |
JP2004500047A (ja) | 1999-10-20 | 2004-01-08 | ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン | キメラ免疫原性組成物およびこれらをコードする核酸 |
AU2001240791A1 (en) * | 2000-03-11 | 2001-09-24 | Novartis Ag | Sequence |
AU2001271963A1 (en) * | 2000-07-10 | 2002-01-21 | Colorado State University Research Foundation | Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
-
2002
- 2002-07-15 GB GBGB0216414.3A patent/GB0216414D0/en not_active Ceased
-
2003
- 2003-07-14 EP EP03763840A patent/EP1523497B1/en not_active Expired - Lifetime
- 2003-07-14 JP JP2004520618A patent/JP5362167B2/ja not_active Expired - Fee Related
- 2003-07-14 TW TW092119115A patent/TWI332989B/zh not_active IP Right Cessation
- 2003-07-14 AT AT03763840T patent/ATE499381T1/de not_active IP Right Cessation
- 2003-07-14 DE DE60336141T patent/DE60336141D1/de not_active Expired - Lifetime
- 2003-07-14 BR BR0312700-1A patent/BR0312700A/pt not_active IP Right Cessation
- 2003-07-14 CA CA2492556A patent/CA2492556C/en not_active Expired - Fee Related
- 2003-07-14 AU AU2003250943A patent/AU2003250943B2/en not_active Ceased
- 2003-07-14 CN CNB038170477A patent/CN100378124C/zh not_active Expired - Fee Related
- 2003-07-14 WO PCT/EP2003/007602 patent/WO2004007539A2/en active Application Filing
- 2003-07-14 US US10/521,103 patent/US7674892B2/en not_active Expired - Fee Related
- 2003-07-14 DK DK03763840.0T patent/DK1523497T3/da active
-
2005
- 2005-02-10 NO NO20050721A patent/NO337573B1/no not_active IP Right Cessation
- 2005-09-14 HK HK05108041.7A patent/HK1075901A1/xx not_active IP Right Cessation
-
2007
- 2007-09-28 CL CL200702806A patent/CL2007002806A1/es unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108929880A (zh) * | 2012-03-27 | 2018-12-04 | 库瑞瓦格股份公司 | 包含5′toputr的人工核酸分子 |
CN103405763A (zh) * | 2013-07-15 | 2013-11-27 | 中国科学院海洋研究所 | 热休克蛋白70作为免疫佐剂的应用 |
CN106282196A (zh) * | 2016-08-20 | 2017-01-04 | 辽宁省海洋水产科学研究院 | 中华绒螯蟹hsp90基因克隆及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CA2492556A1 (en) | 2004-01-22 |
WO2004007539A2 (en) | 2004-01-22 |
BR0312700A (pt) | 2005-04-19 |
JP5362167B2 (ja) | 2013-12-11 |
WO2004007539A3 (en) | 2004-02-19 |
EP1523497B1 (en) | 2011-02-23 |
NO337573B1 (no) | 2016-05-09 |
US20050136071A1 (en) | 2005-06-23 |
JP2006514537A (ja) | 2006-05-11 |
EP1523497A2 (en) | 2005-04-20 |
HK1075901A1 (en) | 2005-12-30 |
GB0216414D0 (en) | 2002-08-21 |
CA2492556C (en) | 2014-09-16 |
TWI332989B (en) | 2010-11-11 |
AU2003250943A1 (en) | 2004-02-02 |
AU2003250943B2 (en) | 2007-08-16 |
CL2007002806A1 (es) | 2008-02-01 |
DE60336141D1 (en) | 2011-04-07 |
NO20050721D0 (no) | 2005-02-10 |
CN100378124C (zh) | 2008-04-02 |
US7674892B2 (en) | 2010-03-09 |
ATE499381T1 (de) | 2011-03-15 |
NO20050721L (no) | 2005-04-14 |
DK1523497T3 (da) | 2011-05-16 |
TW200401827A (en) | 2004-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1193094C (zh) | 虾白斑综合征病毒抗原蛋白及其用途 | |
NO337573B1 (no) | Kimær nukleinsyresekvens omfattende Hsp70-sekvensen fra Arthrobacter og nukleinsyre-ekspresjonsvektor omfattende denne, vertcelle og fusjonsprotein, samt vaksinepreparet og anvendelser for fremstilling av et vaksinepreparat for vaksinering av fisk eller et medikament for forebyggelse eller behandling av infeksiøs sykdom hos fisk. | |
CN1056428A (zh) | 放线杆菌胸膜肺炎亚单元疫苗 | |
CA2407301C (en) | Hsp60 sequence from piscirickettsia salmonis | |
US7803924B2 (en) | HSP60 from arthrobacter | |
CN1589901A (zh) | 一种口蹄疫双价多肽疫苗及其制备方法和用途 | |
CN1803194A (zh) | 用于预防鸡球虫病的免疫调节型dna疫苗 | |
CN1249240C (zh) | 表达载体pBVTB及其构建方法和在HCV疫苗研究中的应用 | |
CN1160125C (zh) | 一种免疫防龋dna疫苗及制备方法和应用 | |
CN1634978A (zh) | Sars病毒hla-a2限制性表位多肽及其应用 | |
US7842296B2 (en) | Sequences from Piscirickettsia salmonis | |
CN1763105A (zh) | 激发机体产生fmdv抗体的融合蛋白及其编码基因与应用 | |
CN1468958A (zh) | 一种口蹄疫双价多肽疫苗基因合成及高效表达方法 | |
CN1072454A (zh) | 重组无毒沙门氏菌抗育性疫苗 | |
CN1414015A (zh) | 新的钩端螺旋体外膜蛋白、其编码序列及用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1079217 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1079217 Country of ref document: HK |
|
C56 | Change in the name or address of the patentee |
Owner name: NOVARTIS CO., LTD. Free format text: FORMER NAME: NOVARTIS AG |
|
CP01 | Change in the name or title of a patent holder |
Address after: Basel Patentee after: Novartis Ag Address before: Basel Patentee before: Novartis AG |
|
ASS | Succession or assignment of patent right |
Owner name: SWISS NOVARTIS ANIMAL HEALTH CO., LTD. Free format text: FORMER OWNER: NOVARTIS CO., LTD. Effective date: 20150424 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150424 Address after: Basel Patentee after: Animal health company limited of Novartis of Switzerland Address before: Basel Patentee before: Novartis Ag |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080402 Termination date: 20170714 |
|
CF01 | Termination of patent right due to non-payment of annual fee |